190 related articles for article (PubMed ID: 16007735)
1. Golden opportunities.
Smaglik P
Nature; 2005 Jul; 436(7047):144-7. PubMed ID: 16007735
[No Abstract] [Full Text] [Related]
2. Value creation and sharing among universities, biotechnology and pharma.
Edwards MG; Murray F; Yu R
Nat Biotechnol; 2003 Jun; 21(6):618-24. PubMed ID: 12776145
[No Abstract] [Full Text] [Related]
3. Biotechs hold their own in shifting industry.
Mitchell P
Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
[No Abstract] [Full Text] [Related]
4. Blurred vision.
Smaglik P
Nature; 2002 Dec; 420(6916 Suppl):A19, A21, A23. PubMed ID: 12501122
[No Abstract] [Full Text] [Related]
5. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
6. Northern England: rising star.
Smaglik P
Nature; 2003 Sep; 425(6956):430-3. PubMed ID: 14508497
[No Abstract] [Full Text] [Related]
7. UK industry consolidation is slow despite big merger.
Mitchell P
Nat Biotechnol; 2003 Mar; 21(3):215. PubMed ID: 12610553
[No Abstract] [Full Text] [Related]
8. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
Scattereggia J
IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
[TBL] [Abstract][Full Text] [Related]
9. Antisoma-Roche deal--a new kind of buyout?
Mitchell P
Nat Biotechnol; 2003 Jan; 21(1):3. PubMed ID: 12511894
[No Abstract] [Full Text] [Related]
10. Fresh horizons South Korea.
Cyranoski D
Nature; 2002 Dec; 420(6916):4-5. PubMed ID: 12478244
[No Abstract] [Full Text] [Related]
11. China's Zhejiang province is open for science business.
O'Meara S
Nature; 2018 May; 557(7707):S51-S52. PubMed ID: 29849161
[No Abstract] [Full Text] [Related]
12. Should platform companies move toward products?
Ratner M
Nat Biotechnol; 1999 Jan; 17(1):16-7. PubMed ID: 9920255
[No Abstract] [Full Text] [Related]
13. Cheap at any price?
Ledford H
Nature; 2007 May; 447(7141):131. PubMed ID: 17495898
[No Abstract] [Full Text] [Related]
14. Calling for entrepreneurs: London.
Smaglik P
Nat Biotechnol; 2002 Dec; 20(12):1281-2. PubMed ID: 12454679
[No Abstract] [Full Text] [Related]
15. Best of both worlds.
Smaglik P
Nature; 2003 Dec; 426(6967):706-7. PubMed ID: 14668875
[No Abstract] [Full Text] [Related]
16. Cementing links between industry and the university.
Jennings R
Nat Biotechnol; 1998 May; 16 Suppl():35-6. PubMed ID: 9591263
[No Abstract] [Full Text] [Related]
17. Corporate venture capital and Cambridge.
McCammon MG; Pio E; Barakat S; Vyakarnam S
Nat Biotechnol; 2014 Oct; 32(10):975-8. PubMed ID: 25299912
[No Abstract] [Full Text] [Related]
18. Curiosity makes way for capitalism.
Cyranoski D
Nature; 2004 May; 429(6988):216-9. PubMed ID: 15141220
[No Abstract] [Full Text] [Related]
19. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
[No Abstract] [Full Text] [Related]
20. [Change the world through business partnering - commercialization of biotechnology and open-innovation].
Tsukamoto Y
Nihon Yakurigaku Zasshi; 2013 May; 141(5):268-74. PubMed ID: 23665558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
